PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1733986
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1733986
Global Lung Exercise Machines Market to Reach US$489.8 Million by 2030
The global market for Lung Exercise Machines estimated at US$408.9 Million in the year 2024, is expected to reach US$489.8 Million by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Three-chamber Lung Exercise Machine, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$292.1 Million by the end of the analysis period. Growth in the Two-chamber Lung Exercise Machine segment is estimated at 4.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$111.4 Million While China is Forecast to Grow at 5.6% CAGR
The Lung Exercise Machines market in the U.S. is estimated at US$111.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$95.4 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.
Global Lung Exercise Machines Market - Key Trends & Drivers Summarized
Why Are Lung Exercise Machines Gaining Prominence Across Clinical, Athletic, and Home Health Settings?
Lung exercise machines-also known as respiratory trainers or incentive spirometers-are becoming increasingly integral to pulmonary health management as global awareness grows around respiratory function optimization and rehabilitation. These devices, designed to improve lung capacity, strengthen respiratory muscles, and promote mucus clearance, are used across a broad spectrum of applications-from post-operative recovery and COPD management to athletic training and home-based therapy for chronic conditions. Their non-invasive nature, low cost, and ease of use make them a popular adjunct to traditional respiratory treatments.
Demand has increased notably due to the rising prevalence of chronic respiratory diseases, including asthma, bronchitis, and chronic obstructive pulmonary disease (COPD), particularly in aging populations and high-pollution geographies. Additionally, the COVID-19 pandemic accelerated the adoption of lung training tools among both recovering patients and the general public aiming to build respiratory resilience. Healthcare systems are incorporating these devices in both inpatient and outpatient rehabilitation protocols, while individual users are purchasing them for preventive wellness and recovery from respiratory infections or sedentarism-induced deconditioning.
How Are Design Innovations and Digital Features Enhancing Functionality and Patient Engagement?
Modern lung exercise machines are undergoing significant enhancements in ergonomics, feedback mechanisms, and data integration to improve patient adherence and therapy outcomes. While basic models continue to utilize mechanical resistance, more advanced versions now include threshold resistance technology, oscillatory mechanisms, and electronic airflow sensors that offer real-time feedback. Devices like PEP (positive expiratory pressure) therapy tools and IMT (inspiratory muscle trainers) are being tailored to specific user profiles, including geriatrics, pediatrics, and athletes, with variable resistance settings and interchangeable mouthpieces for personalized comfort and hygiene.
Digital innovation is playing a transformative role in respiratory rehabilitation. Smart lung trainers equipped with Bluetooth connectivity and mobile apps now allow users to monitor performance metrics such as inspiratory volume, peak flow rate, and breath-hold duration. These platforms support guided training sessions, progress tracking, and remote monitoring by clinicians-ensuring continuity of care in decentralized health settings. In some cases, gamified interfaces and virtual coaching modules are used to improve motivation, particularly in pediatric and post-COVID rehabilitation programs. These design improvements are making lung exercise therapy more engaging, accountable, and clinically effective.
Which Patient Groups and Therapeutic Settings Are Driving Demand Diversification?
The lung exercise machine market serves a wide range of end-users, each with distinct therapeutic needs. Hospital use remains a major segment, especially for patients recovering from thoracic or abdominal surgery, where these devices help prevent postoperative complications such as atelectasis or pneumonia. Pulmonary rehabilitation centers use them in conjunction with oxygen therapy, physical conditioning, and medication to manage COPD, cystic fibrosis, and interstitial lung disease. Devices are also deployed in sleep clinics and long-term care facilities to address breathing irregularities and prevent lung volume loss in immobile patients.
Outside clinical settings, there is growing adoption among amateur and professional athletes seeking to enhance respiratory endurance and performance. Breath training is increasingly used in sports such as cycling, swimming, martial arts, and freediving. Moreover, the rise of home healthcare and tele-rehabilitation-driven by aging populations, caregiver shortages, and healthcare cost containment-is pushing device makers to offer affordable, portable, and user-friendly lung trainers for remote respiratory therapy. Patients with post-viral fatigue, long COVID symptoms, and sedentary lifestyle-associated deconditioning are among the fastest-growing user bases in this segment.
What Is Driving Sustained Growth in the Lung Exercise Machines Market Globally?
The growth in the lung exercise machines market is driven by intersecting trends in population health, preventative care, and healthcare system optimization. Rising incidence of respiratory and cardiac conditions-combined with growing recognition of respiratory muscle weakness as a modifiable risk factor-is propelling both clinical recommendation and consumer adoption of respiratory trainers. Post-pandemic awareness of lung health has also heightened the role of such devices in preventive wellness regimes, occupational health programs, and recovery from environmental pollutant exposure.
Technological integration is further boosting demand. The convergence of medical-grade hardware with app-based analytics and clinician dashboards is creating new value propositions for health systems, insurers, and employers offering wellness benefits. Educational initiatives from physiotherapy associations, respiratory therapist networks, and fitness influencers are expanding consumer understanding of how these devices work and who can benefit from them. Online retail platforms and subscription-based device rental models are improving accessibility, particularly in developing markets and under-served rural areas.
Moreover, the market is benefiting from regulatory recognition and reimbursement in certain jurisdictions, especially for COPD, asthma, and post-operative care. Ongoing clinical trials examining the benefits of structured lung training in managing long COVID, neurodegenerative diseases, and sleep apnea may further expand indications and institutional acceptance. As healthcare shifts from reactive to proactive models, lung exercise machines are expected to play a long-term role in respiratory optimization, functional recovery, and chronic disease prevention across diverse populations.
SCOPE OF STUDY:
The report analyzes the Lung Exercise Machines market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Three-chamber Lung Exercise Machine Type, Two-chamber Lung Exercise Machine Type, One-chamber Lung Exercise Machine Type); Application (Asthma Application, Chronic Obstructive Pulmonary Disease Application, Cystic Fibrosis Application, Pneumonia Application, Other Applications); End User (Hospitals & Clinics End User, Homecare End User)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 39 Featured) -
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.